Therefore the high expression of p19Arf in preneoplastic tissues, already evident in non-rhabdomyosarcoma prone urethral tissues of HER-2/neu transgenic mice and of p53TM/TM mice, was further increased by the combined action of HER-2/neu activation and p53 inactivation. The gene discussed is TP53; the disease is rhabdomyosarcoma.